Singapore, Singapore · Founded 2016 · Privately Held (backing)
Developer of an immune profiling system and analytical tools designed to support immunotherapy clinical development. ImmunoScape is based in Singapore, Singapore and was founded in 2016. Its last reported valuation was $80.8 million in Jun 2025. It has raised $60.4 million.
Last reported valuation
$80.8M
Oct 2026
Priced at
—
Total raised
$60.4M
Last round
—
Cap table — not yet on record
ImmunoScape's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of ImmunoScape with a free account
·Watch ImmunoScape: the Monday email on marks, rounds and moves
